Loading clinical trials...
Loading clinical trials...
This study aims to evaluate the diagnostic value of transcranial Doppler ultrasonography (TCD) for evaluating neonatal craniocerebral injuries.
A high-risk neonate refers to an infant, irrespective of gestational age or birth weight, who exhibits an elevated likelihood of experiencing health complications or death. Preterm infants, defined as those born alive at a gestational age of less than 37 weeks, have seen increased birth and survival rates due to advancements in medical technology and the widespread establishment of Neonatal Intensive Care Units (NICUs). Neonatal sepsis is one of the leading causes of morbidity and mortality among term and preterm infants worldwide. Transcranial Doppler ultrasonography (TCD) is the only noninvasive method that enables reliable evaluation of blood flow in the basal intracerebral vessels, providing physiological information complementary to anatomic imaging. TCD is relatively inexpensive, can be performed at the bedside, and enables monitoring in acute emergency settings and for prolonged periods with high temporal resolution, making it ideal for studying dynamic cerebrovascular responses.
Age
0 - 0 years
Sex
ALL
Healthy Volunteers
No
Kafrelsheikh University
Kafr ash Shaykh, Kafrelsheikh, Egypt
Start Date
January 6, 2026
Primary Completion Date
December 30, 2026
Completion Date
December 30, 2026
Last Updated
January 8, 2026
60
ESTIMATED participants
Transcranial Doppler ultrasound
DEVICE
Lead Sponsor
Kafrelsheikh University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions